Zenas BioPharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Zenas BioPharma Inc
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Zenas BioPharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Zenas BioPharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Zenas BioPharma Inc is ZBIO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Zenas BioPharma Inc has its primary listing on NASDAQ (Small cap). You can trade Zenas BioPharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zenas BioPharma Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Zenas BioPharma Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Zenas BioPharma Inc.